# Investment Thesis (Board-Ready)

> **Purpose**: Articulate a compelling, evidence-based investment case that enables executives and investors to make informed capital allocation decisions. This is the "one-pager" that answers "Why should we invest in this?"

## Executive Investment Summary

| Element | Description |
|---------|-------------|
| **Opportunity** | [Market opportunity size in $ — reference TAM/SAM/SOM] |
| **Solution** | [One-sentence description of what we're building] |
| **Moat** | [Sustainable competitive advantage — why we win] |
| **Ask** | [Investment required: $X over Y months] |
| **Return** | [Expected ROI / multiples / payback period] |

---

## Investment Highlights

### 1. Market Opportunity

| Metric | Value | Source | Confidence |
|--------|:-----:|--------|:----------:|
| TAM | $[X]B | [Source] | H/M/L |
| SAM | $[X]M | [Calculation] | H/M/L |
| SOM (3-year) | $[X]M | [Analysis] | H/M/L |
| Market CAGR | [X]% | [Source] | H/M/L |

**Why Now?**
- [Timing factor 1: Technology enabler, regulatory change, behavior shift]
- [Timing factor 2]
- [Timing factor 3]

### 2. Competitive Advantage

| Moat Type | Our Advantage | Durability | Evidence |
|-----------|---------------|:----------:|----------|
| [Network Effects] | [Description] | [X] years | [Source] |
| [Switching Costs] | [Description] | [X] years | [Source] |
| [Scale Economies] | [Description] | [X] years | [Source] |
| [Brand/Trust] | [Description] | [X] years | [Source] |
| [IP/Technology] | [Description] | [X] years | [Source] |

### 3. Business Model

| Metric | Current | Year 1 | Year 3 | Year 5 |
|--------|:-------:|:------:|:------:|:------:|
| Revenue | $[X]K | $[X]K | $[X]M | $[X]M |
| Gross Margin | [X]% | [X]% | [X]% | [X]% |
| Customers | [X] | [X] | [X] | [X] |
| ARPU | $[X] | $[X] | $[X] | $[X] |

**Unit Economics (at scale)**:
- CAC: $[X]
- LTV: $[X]
- LTV:CAC: [X]:1
- Payback: [X] months

---

## Key Assumptions

| # | Assumption | Evidence | Confidence | Sensitivity |
|---|------------|----------|:----------:|:-----------:|
| 1 | [Market will grow at X%] | [Source] | H/M/L | High/Med/Low |
| 2 | [We can achieve X% conversion] | [Data/comparable] | H/M/L | High/Med/Low |
| 3 | [CAC will decrease to $X] | [Analysis] | H/M/L | High/Med/Low |
| 4 | [Churn will stabilize at X%] | [Benchmark] | H/M/L | High/Med/Low |
| 5 | [Technology X will be ready by Y] | [Roadmap] | H/M/L | High/Med/Low |

### Assumption Validation Plan

| Assumption | Validation Method | Timeline | Budget |
|------------|------------------|:--------:|:------:|
| [Assumption 1] | [Customer interviews, A/B test, etc.] | [X] weeks | $[X]K |
| [Assumption 2] | [Pilot program, market test, etc.] | [X] weeks | $[X]K |

---

## Risk-Adjusted Returns

### Scenario Analysis

| Scenario | Probability | Revenue Y3 | NPV | IRR | Key Drivers |
|----------|:-----------:|:----------:|:---:|:---:|-------------|
| **Upside** | [X]% | $[X]M | $[X]M | [X]% | [Key assumption exceeds] |
| **Base** | [X]% | $[X]M | $[X]M | [X]% | [Plan execution] |
| **Downside** | [X]% | $[X]M | $[X]M | [X]% | [Key risk materializes] |

**Expected Value**: $[X]M (probability-weighted NPV)

### Risk Factors

| Risk | Probability | Impact | Mitigation | Residual Risk |
|------|:-----------:|:------:|------------|:-------------:|
| [Market risk] | H/M/L | H/M/L | [Strategy] | H/M/L |
| [Competitive risk] | H/M/L | H/M/L | [Strategy] | H/M/L |
| [Execution risk] | H/M/L | H/M/L | [Strategy] | H/M/L |
| [Technology risk] | H/M/L | H/M/L | [Strategy] | H/M/L |

---

## Investment Request

### Use of Funds

| Category | Amount | % of Total | Purpose |
|----------|:------:|:----------:|---------|
| Product Development | $[X]K | [X]% | [Specific deliverables] |
| Go-to-Market | $[X]K | [X]% | [Specific activities] |
| Operations | $[X]K | [X]% | [Infrastructure, team] |
| Contingency | $[X]K | [X]% | Risk buffer |
| **TOTAL** | **$[X]K** | **100%** | |

### Milestones & Tranches

| Milestone | Target Date | Investment | Success Criteria |
|-----------|:-----------:|:----------:|------------------|
| [Milestone 1: MVP] | Q[X] 202X | $[X]K | [Measurable outcome] |
| [Milestone 2: Product-Market Fit] | Q[X] 202X | $[X]K | [Measurable outcome] |
| [Milestone 3: Scale] | Q[X] 202X | $[X]K | [Measurable outcome] |

### Kill Criteria

| Condition | Trigger | Action |
|-----------|---------|--------|
| [Market invalidation] | [Specific metric below X] | Pivot or wind down |
| [Competitive displacement] | [Specific event] | Reassess strategy |
| [Execution failure] | [Milestone missed by X months] | Leadership review |

---

## Comparable Transactions

| Company/Deal | Stage | Investment | Valuation | Outcome | Relevance |
|--------------|:-----:|:----------:|:---------:|:-------:|-----------|
| [Comparable 1] | [Series X] | $[X]M | $[X]M | [X]x return | [Why relevant] |
| [Comparable 2] | [Acquisition] | $[X]M | $[X]M | [X]x return | [Why relevant] |
| [Comparable 3] | [IPO] | $[X]M | $[X]B | [X]x return | [Why relevant] |

---

## Team & Execution Capability

| Role | Person/Gap | Relevant Experience | Confidence |
|------|------------|---------------------|:----------:|
| [CEO/Product Lead] | [Name/TBH] | [Experience] | H/M/L |
| [CTO/Tech Lead] | [Name/TBH] | [Experience] | H/M/L |
| [Sales/GTM Lead] | [Name/TBH] | [Experience] | H/M/L |
| [Domain Expert] | [Name/Advisor] | [Experience] | H/M/L |

**Founder-Market Fit**: [Assessment of why this team is uniquely positioned]

---

## Investment Thesis Quality Checklist

- [ ] One-page summary is compelling and complete
- [ ] Market opportunity is quantified with sources
- [ ] Competitive moat is articulated and defensible
- [ ] Unit economics are realistic (benchmarked to comparables)
- [ ] Key assumptions are explicit with validation plan
- [ ] Scenario analysis includes base/upside/downside
- [ ] Use of funds is specific and tied to milestones
- [ ] Kill criteria are defined (prevents throwing good money after bad)
- [ ] Comparable transactions support valuation expectations
- [ ] Team gaps are acknowledged with hiring plan

---

## Integration Notes

- **Feeds into**: Strategic Alternatives (defines the "BUILD" option), Portfolio Context (capital allocation)
- **Depends on**: Market Framework (TAM/SAM/SOM), Business Model Canvas (unit economics), Risk Matrix
- **CQS Impact**: Core component of Strategic Depth (+5 pts) and Validation Rigor (+3 pts)
- **Board Usage**: This section can be extracted as a standalone board memo
